Post-approval studies (Phase 4)Study completedNCT01611077
What this trial is testing
Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg
Who this might be right for
Hypertension
Institut für Pharmakologie und Präventive Medizin 88